Company - Medical Advisory

Uscom announced in September 2002 the formation of its Medical and Technology Advisory Board.
The company is proud to be associated with scientists with high international caliber, bringing to the company a wide range of skills and experience in medicine and technology.

• The members of the Advisory Board are:
• Rob Phillips MPhil(Med), FIR, DMU(Cardiol), AMS. Chairman and Director
  of Clinical Science, Uscom Ltd
• Dr Stephane Carlier MD, PhD Cardiologist, Biomedical Engineer
• Prof Colin Sullivan BsC(Med), MB, BS, PhD, FRACP, FTSE, FAA University of Sydney
• Prof Malcolm West MBBS, PhD, FRACP University of Queensland
• Prof C P Lau MBBS, MD, MRCP, FRCP, FACC, FRCP, FRACP, FESC Hong Kong University
• Prof Didier Payen MD Lariboisiere Hospital, Paris
• Prof Peter Lichtenthal University of Arizona

Uscom is committed to the development and marketing of unique, innovative and worthwhile solutions for worldwide health care markets. It is the company's intention to maintain the highest professional and ethical standards in all of its activities across science and business
The role of the Advisory Board is to provide research guidance and augment the company's current research programmes in both the medical and technology fields. The Advisory Board will assist in the identification and development of new and promising medical technologies for the Company.
Uscom is especially pleased to have Professor Colin Sullivan as a member of the Advisory Board.
Professor Sullivan is the inventor of ResMed's nasal CPAP for treating obstructive sleep apnea and former Chairman of ResMed's Medical Advisory Board. He is Professor of Medicine, and Head of the Centre for Respiratory Failure and Sleep Disorders, as well as a thoracic physician at the Royal Prince Alfred Hospital. He is Director of the David Read Research Laboratory and Director of the Australian Centre for Advanced Medical Technology at the Sydney University Medical School.